9 Key Themes for PPP Track 2026
1. Simplification Omnibus: Unlimited approvals framework
The elimination of mandatory renewals for active substances ends the approval bottleneck. Enhanced Union Authorisation and mutual recognition mechanisms enable simultaneous multi-Member State market access.
2. Environmental monitoring and water quality
Competent authorities use monitoring data to identify structural exceedances of Regulatory Acceptable Concentration in surface water. Water Framework Directive integration aligns authorisation criteria with the 2027 deadline requirements.
3. PFAS policy and persistent metabolites
PFAS scrutiny in plant protection products includes "Candidates for Substitution" designations. TFA formation from PFAS creates contamination that conventional drinking water treatment cannot remove.
4. Non-target terrestrial organisms risk assessment
EFSA's Specific Protection Goals address trophic interactions and biodiversity impacts in agricultural systems. Assessment frameworks balance agronomic performance with environmental protection requirements.
5. Endocrine disruption assessment harmonisation
Subtle differences exist between BPR, PPP, and CLP endocrine disruptor criteria. The distinction between "endocrine mode of action" and "endocrine activity" determines assessment stringency.
6. Agriguide and digital labelling regulation
Machine-readable labels enable regulatory oversight and supply chain transparency. Electronic record-keeping requirements transform IPM documentation and audit trails across EU Member States.
7. Data protection and innovation incentives
Extended data protection periods reshape active substance renewal economics. Generic product market entry depends on understanding data protection expiry implications.
8. Maximum residue levels and trade
Food and Feed Omnibus proposals impact MRLs for imported products and export markets. International trade considerations require global harmonisation strategies.
9. Low-risk substances and biological alternatives
Regulatory pathways for non-anticoagulant rodenticides and non-chemical approaches offer market opportunities. Safeners and synergists now require formal approval under new regulatory frameworks.









